Macrophage phenotype insights could improve immunotherapy
A certain macrophage phenotype is more effective than another phenotype commonly used in cell therapy for infiltrating tumours.
List view / Grid view
A certain macrophage phenotype is more effective than another phenotype commonly used in cell therapy for infiltrating tumours.
Don’t miss out on the easier way to do flow cytometry. Learn how to bring speed, throughput, multiplexing and miniaturization, to your bench.
New understanding of “Christchurch mutation” in the APOE gene may lead to novel Alzheimer's disease treatments.
New pathway involved in cellular protein degradation could develop LYTACs therapy and find new treatments for lysosome shortage disorders.
Fatty liver disease treatments may become more effective after identification and greater understanding of more drug targets.
Researchers have engineered CAAR T cells to destroy harmful antibodies, improving NMDA receptor encephalitis treatment.
In rodent and nonhuman primate animals, circuit-specific gene therapy offers promise for Parkinson’s disease and other brain disorders.
Researchers have developed a new bioreactor that can manufacture T cells faster than other technologies, which may advance immunotherapy.
An epitope on CD95 receptor causes tumour cells to self-destruct and may prolong benefits of CAR T-cell therapy for solid tumours.
Scientists have developed ExoCaps, self-healing microcapsules that are more feasible than other cell-based technologies.
New research improves patient care by finding where gene copies integrate into DNA and using lentiviral vectors.
CRISPR-DREAM tool used to activate insufficiently expressed genes and convert skin cells to induced pluripotent stem cells (iPSCs).